How Epstein Mania Finally Let Democrats Talk (and Meme) Like the Right

Hoping to widen the rift between Trump and his supporters, a few Democrats are dabbling in the kind of messaging that usually punches left.Read More
Tariffs on China Set to Rise Sharply Tuesday if No Deal Is Reached

President Trump has yet to formally sign off on an agreement to extend an economic cease-fire with China.Read More
Judge in Maxwell Case Will Not Unseal Grand Jury Transcripts

President Trump has tried to subdue criticism and conspiracy theories by pushing to disclose the transcripts from the cases of Jeffrey Epstein, who abused teenage girls, and Ghislaine Maxwell, who assisted him.Read More
Higher Tariffs Loom as U.S.-China Trade Truce Nears Expiration

President Trump has yet to formally sign off on an agreement to extend an economic cease-fire with China, which expires on Tuesday.Read More
What the Nvidia Chip Payoff Deal Says About Trump’s Trade War

A deal for Nvidia and AMD to give the Trump administration a cut of chip sales to China raises questions about national security and trade policy goals.Read More
A Sidelined Zelensky Warns That Russia Will Try to Deceive the U.S.

Ukraine fears that the Kremlin will try to convince President Trump at U.S.-Russian talks in Alaska that Ukraine, not Russia, is the obstacle to peace.Read More
Israel’s Plan for Gaza City Is Still Unclear

The Israeli government said last week that it wanted to capture Gaza City, but how and when it will proceed has yet to be decided.Read More
Kennedy’s Next Target: the Federal Vaccine Court

The system for compensating people injured by vaccines needs significant reform. But the health secretary could alter it in ways that ultimately reduce vaccine access for everyone.Read More
This Ohio Farm Community Is a Mecca for the ‘MAHA Mom’

In a neighborhood that appeals to people from both the right and the left, residents strive for a finely tuned state of political harmony.Read More
The Harvard-Trained Lawyer Behind Trump’s Fight Against Top Universities

May Mailman is credited as an animating force behind a strategy that has intimidated independent institutions and undercut years of medical and scientific research.Read More